Financial calendar

  • Year-end report 2017

    2018-02-15

  • Interim report Q1 2018

    2018-04-24

  • Interim report Q2 2018

    2018-08-21

  • Interim report Q3 2018

    2018-10-23

  • Year-end report 2018

    2019-02-12

Idogen develops tolerogenic vaccines – long-acting treatment of autoimmune diseases which currently cannot be cured.